JPMorgan Chase & Co’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Buy |
|
|||||
|
2025
Q1 | $1.53M | Buy |
|
|||||
|
2024
Q4 | $861K | Buy |
|
|||||
|
2024
Q3 | $411K | Buy |
|
|||||
|
2024
Q2 | $183K | Buy |
|
|||||
|
2024
Q1 | $118K | Sell |
|
|||||
|
2023
Q4 | $129K | Sell |
|
|||||
|
2023
Q3 | $7.01M | Sell |
|
|||||
|
2023
Q2 | $7.95M | Sell |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $16.9M | Buy |
|
|||||
|
2022
Q3 | $28.3M | Sell |
|
|||||
|
2022
Q2 | $19.2M | Buy |
|
|||||
|
2022
Q1 | $35M | Sell |
|
|||||
|
2021
Q4 | $57.1M | Buy |
|
|||||
|
2021
Q3 | $56.7M | Buy |
|
|||||
|
2021
Q2 | $70M | Buy |
|
|||||
|
2021
Q1 | $53.1M | Buy |
|
|||||
|
2020
Q4 | $65.6M | Buy |
|
|||||
|
2020
Q3 | $44.2M | Buy |
|
|||||
|
2020
Q2 | $41.7M | Buy |
|
|||||
|
2020
Q1 | $30.3M | Buy |
|
|||||
|
2019
Q4 | $47.5M | Buy |
|
|||||
|
2019
Q3 | $28.4M | Buy |
|
|||||
|
2019
Q2 | $26.3M | Buy |
|
|||||
|
2019
Q1 | $21.7M | Buy |
|
|||||
|
2018
Q4 | $5.51M | Buy |
|
|||||
|
2018
Q3 | $6.54M | Sell |
|
|||||
|
2018
Q2 | $8.43M | Sell |
|
|||||
|
2018
Q1 | $6.7M | Sell |
|
|||||
|
2017
Q4 | $5.16M | Buy |
|
|||||
|
2017
Q3 | $35K | Buy |
|
|||||
|
2017
Q2 | $28K | Sell |
|
|||||
|
2017
Q1 | $1.04M | Buy |
|
|||||
|
2016
Q4 | $884K | Buy |
|
|||||
|
2016
Q3 | $1.12M | Sell |
|
|||||
|
2016
Q2 | $6.08M | Sell |
|
|||||
|
2016
Q1 | $6.62M | Buy |
|
|||||
|
2015
Q4 | $8.78M | Buy |
|
|||||
|
2015
Q3 | $4.21M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $176K | Buy |
|